News

Arcus Biosciences' cancer drug candidate, quemliclustat, earns FDA orphan drug status, ensuring incentives and exclusivity.
The Trump administration will revoke the legal status and work permits of hundreds of thousands of Haitian migrants in early September.
Ultragenyx stock rises after FDA grants breakthrough therapy status for Angelman syndrome drug Editor Luke Juricic Stock Markets Published 06/27/2025, 08:52 AM ...
Breakthrough Therapy Designation aims to expedite development and review of drugs for serious conditions that demonstrate substantial improvement over existing therapies.
The FDA has granted Orphan Drug designation to riliprubart for the investigational treatment of AMR in solid organ transplantation.
The UK's health regulator is investigating Ozempic and Mounjaro after linking the drugs to hundreds of severe illnesses and deaths.
Treatment of NCSE depends to a large extent on the subtype diagnosed and the circumstances in which SE occurs ( Table 1). The drug regimens described below are applicable to patients of all ages ...
Nonconvulsive status epilepticus (NCSE) encompasses a wide range of diagnoses with variable outcomes and treatment recommendations. In children, NCSE can be observed in various conditions ...
(RTTNews) - The U.S. Food and Drug Administration has granted orphan drug designation to riliprubart for the investigational treatment of antibody-mediated rejection (AMR) in solid organ ...
Oral anticoagulants (OACs) are medications commonly used in patients with atrial fibrillation and other cardiovascular conditions. Both warfarin and direct oral anticoagulants are susceptible to ...
A former Multnomah County corrections deputy is accused of developing a relationship with a man in jail and later smuggling drugs to him.
Capricor Therapeutics' Deramiocel earns Orphan Drug status for Becker muscular dystrophy. Read more here.